Module 5_Future Directions and Key Takeaways_Matthew Davids, MD, MMSc_Jeffrey Bubis, DO, FACOI, FACP_Divis Khaira, MD

Chronic Lymphocytic Leukemia 144 videos

of 14

144 videos

Chronic Lymphocytic Leukemia

Module 5_Future Directions and Key Takeaways_Matthew Davids, MD, MMSc_Jeffrey Bubis, DO, FACOI, FACP_Divis Khaira, MD

8:55
What's Now and Next for CLL_Nicole Lamanna, MD; #IUCLS22

20:13
Expert Guidance on the Optimal Use of Current and Emerging BTK Inhibitors for Patients with CLL_Matthew Davids, MD, MMSc

41:32
Updates in Management for Relapsed and Refractory CLL_Nicole Lamanna, MD; #hemeupdates2022

19:49
Novel Agents in CLL_John Allan, MD; #hemeupdates2022

14:57
New Therapeutic Options in Frontline CLL_Richard Furman, MD; #hemeupdates2022

15:59
New therapeutic options in frontline CLL_Susan O'Brien, MD; #BeyondTheCongress

14:51
Novel agents in CLL_Nitin Jain, MD; #BeyondTheCongress

14:25
Updates in management for relapsed and refractory CLL_Jennifer Brown, MD, PhD; #BeyondTheCongress

14:29
Podium to Practice: Clinical Updates for the Treatment of Patients with CLL from the 2021 Annual Hematology Meeting_Jennifer Woyach, MD_Matthew Davids, MD, MMSc

31:18
Nicole Lamanna, MD; Columbia University Irving Medical Center; 5Live #ASH21

11:27

Key insights from the 2021 Annual Hematology meeting in Atlanta
Next Page

of 14

ABOUT

Bio Ascend is an independent medical education company committed to supporting healthcare providers in their efforts to translate innovative science into clinical practice.

The Bio Ascend team has deep oncology and hematology expertise with a proven ability to distill complex scientific ideas into their essential components, as well as extensive experience in planning, executing, and assessing meaningful education for clinicians.

CONNECT

support@bioascend.com

(888) 476-9129

980 North Michigan Avenue, Suite 1400, Chicago, IL 60611